Get the Stockscreener App
19.84
0.25%
-0.185
Progyny Inc stock is traded at $19.84, with a volume of 9,507.
It is down -0.25% in the last 24 hours and down -9.61% over the past month.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
See More
Previous Close:
$20.03
Open:
$19.98
24h Volume:
9,507
Relative Volume:
0.01
Market Cap:
$1.69B
Revenue:
$1.13B
Net Income/Loss:
$62.75M
P/E Ratio:
31.50
EPS:
0.63
Net Cash Flow:
$170.92M
1W Performance:
-5.75%
1M Performance:
-9.61%
6M Performance:
-17.85%
1Y Performance:
-45.93%
1-Day Range:
$19.98
$19.98
1-Week Range:
$19.54
$21.36
52-Week Range:
$13.39
$38.98
Progyny Inc Stock (PGNY) Company Profile
Name
Progyny Inc
Sector
Industry
Phone
212-888-3124
Address
1359 BROADWAY, NEW YORK, NY
Compare PGNY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
19.98 | 1.69B | 1.13B | 62.75M | 170.92M | 0.63 |
|
UNH
Unitedhealth Group Inc
|
478.24 | 444.64B | 400.28B | 14.41B | 20.71B | 15.50 |
|
ELV
Elevance Health Inc
|
416.68 | 94.86B | 176.81B | 5.98B | 4.55B | 25.61 |
|
CI
Cigna Group
|
310.40 | 85.38B | 244.38B | 3.43B | 8.96B | 12.24 |
|
CVS
Cvs Health Corp
|
65.94 | 82.90B | 372.81B | 4.61B | 6.33B | 3.66 |
|
HUM
Humana Inc
|
254.88 | 30.38B | 117.76B | 1.21B | 2.39B | 9.95 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-13-24 | Downgrade | Truist | Buy → Hold |
| Sep-19-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Aug-07-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jul-16-24 | Initiated | JMP Securities | Mkt Outperform |
| May-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-27-23 | Initiated | Canaccord Genuity | Buy |
| May-22-23 | Initiated | BTIG Research | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-05-23 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-07-22 | Initiated | Truist | Buy |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-22-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-30-21 | Initiated | Berenberg | Buy |
| Aug-12-21 | Initiated | Barclays | Overweight |
| Jun-02-21 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-02-20 | Initiated | Guggenheim | Buy |
| Nov-19-19 | Initiated | Citigroup | Buy |
| Nov-19-19 | Initiated | Goldman | Buy |
| Nov-19-19 | Initiated | JP Morgan | Overweight |
| Nov-19-19 | Initiated | Piper Jaffray | Overweight |
| Nov-19-19 | Initiated | SVB Leerink | Outperform |
View All
Progyny Inc Stock (PGNY) Latest News
Progyny Expands Family Building Solutions with New Parent and Child Well-being Offering - GlobeNewswire
Progyny launches Parent and Child Well-being Offering - TipRanks
Progyny Tackles 40% of Workforce Needs with Game-Changing Parent Support Solution - StockTitan
Mutual of America Capital Management LLC Has $194,000 Stock Position in Progyny, Inc. (NASDAQ:PGNY) - Defense World
Progyny at Leerink’s Global Healthcare Conference: Strategic Expansion Focus By Investing.com - Investing.com Canada
Progyny, Inc. to Participate in Upcoming Investor Conferences - GlobeNewswire
Exclusive Access: Progyny Leadership Reveals Growth Strategy at Triple Healthcare Conference Series - StockTitan
Amalgamated Bank Sells 1,468 Shares of Progyny, Inc. (NASDAQ:PGNY) - Defense World
Truist Financial Corp Cuts Holdings in Progyny, Inc. (NASDAQ:PGNY) - Defense World
Decoding Progyny Inc (PGNY): A Strategic SWOT Insight - GuruFocus.com
Progyny, Inc. SEC 10-K Report - TradingView
Health Insurance Providers Q4 Earnings: Progyny (NASDAQ:PGNY) Simply the Best - The Globe and Mail
Progyny, Inc. (PGNY) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates - ACCESS Newswire
Progyny, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - Simply Wall St
Principal Financial Group Inc. Sells 419,185 Shares of Progyny, Inc. (NASDAQ:PGNY) - Defense World
Progyny (NASDAQ:PGNY) Shares Gap Up Following Analyst Upgrade - Defense World
Progyny Full Year 2024 Earnings: Beats Expectations - Yahoo Finance
Rhumbline Advisers Lowers Stock Position in Progyny, Inc. (NASDAQ:PGNY) - Defense World
Progyny, Inc. Reports Strong 2024 Earnings with Optimistic Outlook - TipRanks
Progyny (NASDAQ:PGNY) Issues Earnings Results, Misses Estimates By $0.28 EPS - MarketBeat
Progyny (NASDAQ:PGNY) Issues Q1 2025 Earnings Guidance - MarketBeat
Expert Outlook: Progyny Through The Eyes Of 4 Analysts - Benzinga
Progyny price target raised to $23 from $17 at Canaccord - TipRanks
Progyny Tops EPS Forecast, Eyes Growth - MSN
KeyBanc maintains Progyny stock Sector Weight amid strong outlook - Investing.com India
KeyBanc maintains Progyny stock Sector Weight amid strong outlook By Investing.com - Investing.com South Africa
Progyny Tops EPS Forecast, Eyes Growth - The Motley Fool
Cantor Fitzgerald raises Progyny stock target to $26 By Investing.com - Investing.com Canada
Progyny projects slower revenue growth after losing Amazon - Crain's New York Business
Earnings call transcript: Progyny Q4 2024 beats expectations, stock surges - Investing.com India
Cantor Fitzgerald raises Progyny stock target to $26 - Investing.com
Canaccord raises Progyny stock price target to $23, maintains hold By Investing.com - Investing.com Australia
Progyny, Inc. (NASDAQ:PGNY) Q4 2024 Earnings Call Transcript - Insider Monkey
Canaccord raises Progyny stock price target to $23, maintains hold - Investing.com India
Earnings call transcript: Progyny Q4 2024 beats expectations, stock surges By Investing.com - Investing.com South Africa
Progyny Inc (PGNY) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Progyny Reports Strong Q4 2024 Growth and Surpasses Revenue ExpectationsNews and Statistics - IndexBox, Inc.
Progyny, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2025 -February 27, 2025 at 04:09 pm EST - Marketscreener.com
Progyny: Q4 Earnings Snapshot - mySA
Progyny Inc (PGNY) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... - Yahoo Finance
Progyny’s Balanced Outlook: Strong Performance Amidst Transition Challenges and Conservative Projections - TipRanks
Progyny, Inc. Reports Strong 2024 Financial Results - TipRanks
Progyny Q4 Adjusted Earnings, Revenue Increase; Q1, 2025 Outlook Issued -- Shares Jump After Hours - Marketscreener.com
Progyny stock soars 16.9% on earnings beat, strong guidance By Investing.com - Investing.com Australia
Progyny stock soars 16.9% on earnings beat, strong guidance - Investing.com India
Progyny, Inc. Announces Fourth Quarter 2024 Results - The Manila Times
Earnings Flash (PGNY) PROGYNY INC. Reports Q4 Adjusted EPS $0.42 -February 27, 2025 at 04:10 pm EST - Marketscreener.com
Progyny (NASDAQ:PGNY) Posts Better-Than-Expected Sales In Q4, Stock Jumps 14.7% - Yahoo Finance
What To Expect From Progyny’s (PGNY) Q4 Earnings - The Globe and Mail
What To Expect From Progyny Inc (PGNY) Q4 2024 Earnings - GuruFocus.com
What To Expect From Progyny’s (PGNY) Q4 Earnings By Stock Story - Investing.com Canada
Progyny Inc Stock (PGNY) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.16%
1.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):